Skip to main content
. 2022 May 27;14(5):442–451. doi: 10.4240/wjgs.v14.i5.442

Table 2.

Overall survival of the patients with mass-forming intrahepatic cholangiocarcinoma


All (n = 68)
Surgery (n = 49)
Exploration (n = 19)
P value
Follow-up (mo) 1-82 3-82 1-57
Survival < 0.001
1 yr 66.5% 93.5% 5.3%
3 yr 36.3% 49.7% 5.3%
5 yr 9.3% 14.4% 0.00%